Therapeutics NOW

Author Guidelines

Quick Start Guide

Please prepare the manuscript in Word according to the Instructions for Authors with graphics and tables integrated into the text, using the manuscript template available on the website:

Manuscripts must be submitted via: https://mc.manuscriptcentral.com/therapeuticsnow


File submission

The following items should be uploaded:

  • Cover letter
  • Manuscript main document: Please embed the tables/figures/schemes in the relevant positions
  • Graphic files: original ChemDraw files and PNG, preferably in one zip file
  • Graphical abstract: for the table of contents and the first manuscript page
  • Supporting Information: as a separate file


Preparation of text

  • Use the paragraph styles available within the template. Do not create new styles, and do not alter those that are preassigned.
  • The Significance box must contain no more than 590 characters, including spaces.
  • Use only one space after reference numbers, do not use tabs.
  • Captions for graphic files should be given as part of the manuscript text, not as text within the graphic.
  • Ensure that all graphics and tables are mentioned in the text.
  • Avoid underlining and indentations.
  • Follow further instructions as detailed in the manuscript template.

 

Tables

  • Must be created in Word format.
  • Place each item (paragraph, graphic, etc.) in its own cell.

 

Graphic files and photos

We accept JPG, PNG, and TIF files (not less than 300 dpi).

The graphical abstract must respect the following dimensions:

  • Width 7.7 cm (3.0 in.)
  • Height 6.4 cm (2.5 in.)


Article Processing Charges

An article processing charge (APC) will be charged for every accepted manuscript published in Therapeutics NOW. It is currently 3200 EUR / 2875 USD excluding VAT.

An article will be published once payment has been received. You may want to contact your funder about covering these costs. Many grant-giving bodies have special funds reserved for APCs. Please note that there are no submission charges. If you have a submission voucher, no APC will be charged; instead, you will be asked to fill in the code number when asked for payment. Authors with insufficient funding might be eligible for a full or partial APC discount for publication in Therapeutics NOW.


The Editorial Office is happy to offer advice concerning all technical aspects of manuscript submission: TherapeuticsNOW@thieme.de


1 Editorial Policy

Therapeutics NOW is a high-quality, single-anonymized peer-reviewed journal dedicated to the publication of cutting-edge research in the field of innovative medical treatments and technologies. The journal serves as a platform for scientists, clinicians, and industry experts to share groundbreaking advancements in areas such as gene therapy, immunotherapy, drug discovery, and personalized medicine. Therapeutics NOW spans the scope of research from bench to bedside for results aimed at the development of next-generation therapeutics.


1.1 Journal Scope

Therapeutics NOW covers mainly but not exclusively the following areas of evidence-based research:

  • Applied disease therapeutic research; molecular designs, nanomedicine, theranostics
  • Small and large molecule therapeutics, including macromolecular compounds, nucleic acids, proteins, peptides and nucleotide therapeutics
  • Gene therapy research
  • Drug development for the treatment of common/tropical/infectious diseases
  • Advances in instrument and method development in therapeutic-oriented chemistry and biology
  • Chemistry and synthetic biology focusing on drug/treatment developments, includes prevention treatments e.g. vaccinations
  • Bioengineering and biomaterials for therapeutic application
  • Computational biology with applications to treatment programs
  • Molecular and structural biology/biochemistry, e.g. cellular mechanisms, toxicology, specifically related to drugs or therapeutic programs
  • Use of prediction tools such as AI in drug discovery and healthcare
  • Industrial healthcare policies and solutions
  • Drug-related translational studies
  • Preclinical and phase 1 clinical trial results

 

1.2 Article Types


1.2.1 Original Articles

Full reports of original research that provide dependable research results with detailed and repeatable experimental procedures and full characterization of all important new materials.

1.2.2 Reviews

Review articles provide a comprehensive overview of a current topic, highlighting historical background/origins of a research area and cutting-edge contributions along with the most recent developments. They provide a concise assessment of the current state of the art and an outlook on future developments. Reviews should be up to 25 template-based pages, including tables and graphics.

1.2.3 Graphical Reviews provide a concise overview of a current topic, highlighting historical background/origins of a research area and cutting-edge contributions along with the most recent developments. Text should be limited to a minimum. In preparing graphical reviews, authors should ask themselves how they would prepare lecture notes on the topic.

1.2.4 Registered Reports aim at reducing publication and hypothesis bias by pre-accepting the outlined methodology before the study results have been collected. Registered Reports work in two stages;

Stage 1 (Initial submission): Researchers submit a detailed proposal to a journal outlining the research question, hypothesis, methodology, and planned data analysis. This is done before any data is collected. The proposal is then peer-reviewed, and if it meets the journal’s criteria for scientific rigor and validity, it receives an in-principle acceptance (IPA). This means that the journal agrees to publish the study, regardless of the eventual findings, as long as the research is conducted according to the approved plan.

Stage 2 (Final submission): After the data collection and analysis are completed according to the pre-registered plan, the authors submit the full report. This includes the results, discussion, and conclusions. The final report undergoes a second review to ensure that the methods were followed as described, but the publication decision is not influenced by the outcome of the research.

1.2.5 Industrial Case Studies provide a clear overview on the development of a specific company or industrial sector, including learnings from clinical trials. These articles are written by industrial and applied scientists to inform the readers about the latest challenges in their fields with a call for chemists to help resolve those challenges.


1.3 Thieme’s general Journal Policies

Thieme has outlined its general policies regarding publication ethics and research integrity, including details about authorship and contributorship, research involving animal and human subjects, research misconduct, our policy on prior publication, and much more. These can be found on our Journal Policies webpage (https://www.thieme.com/en-us/journal-policies).


 

Cookie Settings